Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteoporosis Postmenopausal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00790101
What this trial is testing

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 6
Post-approval studies (Phase 4)Study completedNCT04609189
What this trial is testing

Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss

Who this might be right for
Osteoporosis, Postmenopausal
University of Alberta 97
Early research (Phase 1)Study completedNCT00577850
What this trial is testing

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Who this might be right for
OsteopeniaOsteoporosis
Warner Chilcott 32
Large-scale testing (Phase 3)Study completedNCT03710889
What this trial is testing

Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosisOsteoporosis Vertebral+6 more
Radius Health, Inc. 23
Large-scale testing (Phase 3)Study completedNCT00463268
What this trial is testing

Osteoporosis Prevention With Low Dose Alendronate

Who this might be right for
Osteopenia
University Hospital of Mont-Godinne 83
Testing effectiveness (Phase 2)UnknownNCT01834105
What this trial is testing

Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1

Who this might be right for
Postmenopausal Osteoporosis
Fujian Academy of Traditional Chinese Medicine 25
Not applicableUnknownNCT03382366
What this trial is testing

Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women

Who this might be right for
SarcopeniaFalls PatientOsteoporosis, Postmenopausal
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 40
Large-scale testing (Phase 3)Study completedNCT00354302
What this trial is testing

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Who this might be right for
Breast CancerOsteoporosis
NCIC Clinical Trials Group 497
Large-scale testing (Phase 3)Study completedNCT00089791
What this trial is testing

Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Amgen 7,808
Not applicableStudy completedNCT05025917
What this trial is testing

Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal Women

Who this might be right for
Muscle WeaknessOsteoporosis, Postmenopausal
University of Exeter 24
Post-approval studies (Phase 4)Study completedNCT02598440
What this trial is testing

Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 341
Large-scale testing (Phase 3)Study completedNCT04757376
What this trial is testing

Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Celltrion 479
Not applicableStudy completedNCT01572545
What this trial is testing

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

Who this might be right for
Postmenopausal Osteoporosis
Aristotle University Of Thessaloniki 91
Post-approval studies (Phase 4)Study completedNCT00729651
What this trial is testing

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Who this might be right for
Osteoporosis Postmenopausal
Organon and Co 343
Not applicableStudy completedNCT04206618
What this trial is testing

Circulating Myokine Levels and Bone Metabolism

Who this might be right for
Osteoporosis, Postmenopausal
424 General Military Hospital 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT06789900
What this trial is testing

Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women

Who this might be right for
Postmenopausal Women
Odense University Hospital 136
Not applicableStudy completedNCT06264401
What this trial is testing

Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT00715676
What this trial is testing

Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Osteoporosis
Deltanoid Pharmaceuticals 157
Post-approval studies (Phase 4)Study completedNCT03472846
What this trial is testing

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal OsteoporosisDiabetes Type 2
Medical University of Vienna 26
Not applicableStudy completedNCT04653350
What this trial is testing

High Intensity Multi-Modal Exercise Training in Postmenopausal Women

Who this might be right for
Postmenopausal OsteoporosisPostmenopausal Osteopenia
Riphah International University 58
Next Page